83 related articles for article (PubMed ID: 26090600)
21. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
22. Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer.
Gheybi E; Amani J; Salmanian AH; Mashayekhi F; Khodi S
Tumour Biol; 2014 Nov; 35(11):11489-97. PubMed ID: 25128064
[TBL] [Abstract][Full Text] [Related]
23. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.
Guojun W; Wei G; Kedong O; Yi H; Yanfei X; Qingmei C; Yankai Z; Jie W; Hao F; Taiming L; Jingjing L; Rongyue C
Endocr Relat Cancer; 2008 Mar; 15(1):149-59. PubMed ID: 18310283
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patients.
Sperinde J; Jin X; Banerjee J; Penuel E; Saha A; Diedrich G; Huang W; Leitzel K; Weidler J; Ali SM; Fuchs EM; Singer CF; Köstler WJ; Bates M; Parry G; Winslow J; Lipton A
Clin Cancer Res; 2010 Aug; 16(16):4226-35. PubMed ID: 20664024
[TBL] [Abstract][Full Text] [Related]
25. Predicted B-cell epitopes of HER-2 oncoprotein by a bioinformatics method: a clue for breast cancer vaccine development.
Wiwanitkit V
Asian Pac J Cancer Prev; 2007; 8(1):137-8. PubMed ID: 17477789
[TBL] [Abstract][Full Text] [Related]
26. Polyclonal antibodies against gp185HER2 peptides: their putative role in the identification of a particular HER2 status in patients with breast cancer.
Di Modugno F; Buglioni S; Mottolese M; Bello DD; Cascioli S; Chersi A; Santoni A; Nisticò P
J Immunother; 2001; 24(3):221-31. PubMed ID: 11394499
[TBL] [Abstract][Full Text] [Related]
27. Essential roles of tumor-derived helper T cell epitopes for an effective peptide-based tumor vaccine.
Wang L; Miyahara Y; Kato T; Wang L; Aota T; Kuribayashi K; Shiku H
Cancer Immun; 2003 Nov; 3():16. PubMed ID: 14629132
[TBL] [Abstract][Full Text] [Related]
28. Identification of two novel rabbit hemorrhagic disease virus (RHDV) B cell epitopes and evaluation of its immunoprotection against RHDV.
DeSheng K; HuaiRan L; JiaSen L; Zuo Y; Qian J; DongChun G; XiaoLiang H; FengJie W; QianQian H; LianDong Q
Appl Microbiol Biotechnol; 2015 Jul; 99(14):5951-66. PubMed ID: 25895085
[TBL] [Abstract][Full Text] [Related]
29. Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses.
Xie Y; Chen Y; Ahmed KA; Li W; Ahmed S; Sami A; Chibbar R; Tang X; Tao M; Xu J; Xiang J
Cancer Gene Ther; 2013 Oct; 20(10):590-8. PubMed ID: 24052129
[TBL] [Abstract][Full Text] [Related]
30. Antibody response to HER2 extracellular domain and subdomains in mouse following DNA immunization.
Sadri-Ardalani F; Shabani M; Amiri MM; Bahadori M; Emami S; Sarrafzadeh AR; Noutash-Haghighat F; Jeddi-Tehrani M; Shokri F
Tumour Biol; 2016 Jan; 37(1):1217-27. PubMed ID: 26282003
[TBL] [Abstract][Full Text] [Related]
31. P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer.
Shariat S; Badiee A; Jalali SA; Mansourian M; Yazdani M; Mortazavi SA; Jaafari MR
Cancer Lett; 2014 Dec; 355(1):54-60. PubMed ID: 25224570
[TBL] [Abstract][Full Text] [Related]
32. [Preparation and characterization of specific monoclonal antibodies against HER2].
Liu HQ; Wang DM; Qu H; Shi L; Huang LH; Feng CL; Zhang LY; Zhu WB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):456-8. PubMed ID: 20423652
[TBL] [Abstract][Full Text] [Related]
33. Production of mouse monoclonal anti-idiotypic antibodies specific to epitopes of tumor-associated mucin TAG-12.
Schmitt H; Khazaeli MB; Rodenburg CM; Kaul S; Bastert G
Hybridoma; 1994 Oct; 13(5):389-96. PubMed ID: 7532153
[TBL] [Abstract][Full Text] [Related]
34. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene].
Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
[TBL] [Abstract][Full Text] [Related]
36. Antigenic analysis monoclonal antibodies against different epitopes of σB protein of Muscovy duck reovirus.
Li Y; Yin X; Chen X; Li X; Li J; Liu C; Liu M; Zhang Y
Virus Res; 2012 Feb; 163(2):546-51. PubMed ID: 22197425
[TBL] [Abstract][Full Text] [Related]
37. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
Mittendorf EA; Storrer CE; Foley RJ; Harris K; Jama Y; Shriver CD; Ponniah S; Peoples GE
Cancer; 2006 Jun; 106(11):2309-17. PubMed ID: 16596621
[TBL] [Abstract][Full Text] [Related]
39. Induction of monoclonal antibody with predefined ELNKWA epitope specificity by epitope vaccine.
Xiao Y; Dong XN; Chen YH
Hybridoma; 2000 Aug; 19(4):347-50. PubMed ID: 11001409
[TBL] [Abstract][Full Text] [Related]
40. Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts.
Oude Munnink TH; de Vries EG; Vedelaar SR; Timmer-Bosscha H; Schröder CP; Brouwers AH; Lub-de Hooge MN
Mol Pharm; 2012 Nov; 9(11):2995-3002. PubMed ID: 23003202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
